Douglas Shearer, RN, BSN,BLS Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 20 Kent St, Phoenix, NY 13135 Phone: 315-560-3367 |
Mrs. Claudia Sobik, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 11 Elm St, Phoenix, NY 13135 Phone: 315-695-1563 |
Charlene Elizabeth Gill, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 116 Volney St, Phoenix, NY 13135 Phone: 315-695-1524 Fax: 315-695-1544 |
Mrs. Gina Marie Perkins, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24 Spring St, Phoenix, NY 13135 Phone: 315-506-0681 |
Emily Rose Bodway, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 258 Pendergast Rd, Phoenix, NY 13135 Phone: 315-569-5145 |
Mrs. Beth A Whipple, RN Registered Nurse - School Medicare: Not Enrolled in Medicare Practice Location: 552 Main St, Phoenix, NY 13135 Phone: 315-695-1634 Fax: 315-695-1694 |
April Quill, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 242 County Route 12, Phoenix, NY 13135 Phone: 315-882-6548 |
Mrs. Karyn Marie Froio, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11 Elm Street, Phoenix, NY 13135 Phone: 315-695-1561 |
News Archive
Researchers have taken the first step on a path that eventually could result in female mosquitoes that no longer bite and spread diseases.
The University of Illinois at Chicago received $1.7 million in research funding from the U.S. Department of Housing and Urban Development to study lead and other household health hazards. The funds will support two different projects in Illinois communities.
National Autism Association announced Tuesday that the Centers for Disease Control (CDC), Food and Drug Administration (FDA) and some pharmaceutical companies have become a target for investigation.
Cognitive flexibility refers to the ability to readily switch between mental processes in response to external stimuli and different task demands.
PolyMedix, Inc., an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, has successfully completed the first two segments of a Phase 1B clinical safety study with its novel antibiotic drug candidate PMX-30063.
› Verified 8 days ago